Apple has been quietly trying to build a blood sugar sensor that requires zero needles for over 15 years.
That means the project predates the App Store, predates Siri, and predates the Apple Watch itself.
Whatever is happening inside that lab has been going on longer than most people have owned a smartphone.
What Apple is reportedly testing sounds almost too clever to be real. Tiny lasers fire specific wavelengths of light through your wrist, into the fluid that seeps from capillaries just beneath the skin.
Glucose absorbs some of that light. What bounces back tells an algorithm how much sugar is in your blood.
If it works, it would do something that currently costs diabetics thousands of dollars a year in dedicated monitoring equipment from a watch they’re already wearing.
A Leadership Shuffle That Might Actually Mean Something
Oversight of the project recently moved from Apple’s platform architecture chief, Tim Millet, to a senior engineer, Zongjian Chen, who leads advanced technologies at the company.
The reason people inside Apple apparently view this as encouraging is that Chen has a reputation for shipping things.
Moving a moonshot project to an engineer known for execution suggests the work may have crossed an internal threshold, making building toward a real product the next logical step.
Why This Is So Hard to Pull Off
The accuracy problem is brutal. A diabetic managing insulin doses cannot afford a reading that is off by even a modest margin.
Current continuous glucose monitors work because they physically sit in your tissue. Getting the same precision from a light-based sensor worn on the outside of your wrist, on a wrist that moves, sweats, and changes temperature, is a legitimately unsolved engineering problem.
The feature is reportedly still years away, and it may never arrive at all. However, the prediabetes angle is worth watching.
A broader, less precise glucose trend reading could flag risk before someone is diagnosed, which would require a lower accuracy bar and be potentially far easier to clear.
For the roughly 540 million people living with diabetes worldwide, a working version of this would reshape how the disease gets managed every single day.
